Mucosal tolerance to KLH reduces BSA-induced arthritis in rats - An indication of bystander suppression

Journal of Clinical Immunology

Volumn 27, Issue 3, 2007, Pages 284-293

  Freysdottir, Jona ^a,b   Hardardottir, Ingibjorg ^a,c   Gizurarson, Sveinbjorn ^a,c   Vikingsson, Arnor ^a,b  

^a Lyfjathroun Biopharmaceuticals   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Anti inflammatory drugs; BSA induced arthritis; Bystander suppression; Mucosal tolerance; Nasal tolerance; Passive cigarette smoke

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BOVINE SERUM ALBUMIN; KEYHOLE LIMPET HEMOCYANIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BYSTANDER EFFECT; CELLULAR IMMUNITY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INJECTION; KNEE; MUCOSA; NONHUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; RAT;

ANIMALS; ARTHRITIS; BECLOMETHASONE; BYSTANDER EFFECT; CATTLE; CELL PROLIFERATION; FEMALE; HEMOCYANIN; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-10; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; SERUM ALBUMIN, BOVINE; SPLEEN; TOBACCO SMOKE POLLUTION;

EID: 34249038709     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-007-9081-3     Document Type: Article

References (42)

1. + T cells precedes the development of tolerance in vivo. Int Immunol 8:335-342, 1996
2. Mowat AM, Steel M, Worthey EA, Kewin PJ, Garside P: Inactivation of Th1 and Th2 cells by feeding ovalbumin. Ann NY Acad Sci 778:122-132, 1996
3. Barnett ML, Kremer JM, St Clair EW, Clegg DO, Furst D, Weisman M, Fletcher MJ, Chasan-Taber S, et al.: Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 41:290-297, 1998
4. McKown KM, Carbone LD, Bustillo J, Seyer JM, Kang AH: Postlethwaite AE: Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis Rheum 43:1054-1061, 2000
5. Choy EH, Scott DL, Kingsley GH, Thomas S, Murphy AG, Staines N, Panayi GS: Control of rheumatoid arthritis by oral tolerance. Arthritis Rheum 44:1993-1997, 2001
6. Mayer L, Shao L: Therapeutical potential of oral tolerance. Nat Rev Immunol 4:407-419, 2004
7. Harrison LC, Honeyman MC, Steele CE, Stone NL, Sarugeri E, Bonifacio E, Couper JJ, Colman PG: Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 27:2348-2355, 2004
8. Chaillous L, Lefevre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, et al.: Oral insulin administration and residual β-cell function in recent-onset type 1 diabetes: A multicentre randomised controlled trial. Lancet 356:545-549, 2000
9. Pecquet S, Prioult G, Campbell J, German B, Turini M: Commonly used drugs impair oral tolerance in mice. Ann NY Acad Sci 1029:374-378, 2004
10. Postlethwaite AE, Kang AH, Myers JK: NSAIDs abrogate oral tolerance (OT) induction to type II collagen (CII) in DBA/1 mice. Arthritis Rheum 40(Suppl 9):S54, 1997
11. Louis E, Franchimont D, Deprez M, Lamproye A, Schaaf N, Machieu P, Belaiche J: Decrease in systemic tolerance to fed ovalbumin in indomethacin treated mice. Int Arch Allergy Immunol 109:21-26, 1996
12. Yoshino S, Hayashi H, Taneda S, Takano H, Sagai M, Mori Y: Effect of diesel exhaust particle extracts on induction of oral tolerance in mice. Toxicol Sci 66:293-297, 2002
13. Husby S, Mestecky J, Moldoveanu Z, Holland S, Elson CO: Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol 152:4663-4670, 1994
14. Kraus TA, Toy L, Chan L, Childs J, Mayer L: Failure to induce oral tolerance a soluble protein in patients with inflammatory bowel disease. Gastroenterol 126:1771-1778, 2004
15. Untersmayr E, Scholl I, Svoboda I, Beil WJ, Forster-Waldl E, Walter F, Riemer A, Kraml G, et al.: Antacid medication inhibits digestion of dietary proteins and causes food allergy: A fish allergy model in Balb/c mice. J Allergy Clin Immunol 112:616-623, 2003
16. Hukkanen J, Jacob P III, Benowitz NL: Metabolism and disposition kinetics of nicotine. Pharmacol Rev 57:79-115, 2005
17. Cooke TDV: Antigen-induced arthritis, polyarthritis and tenosynovitis. In CRC Handbook of Animal Models for the Rheumatic Diseases, Vol. 1, RA Greenwald, HS Diamond (eds). Florida, CRC Press, 1988, pp 53-81
18. Yoshino S, Yoshino J: Suppression of chronic antigen-induced arthritis in rats by a monoclonal antibody against the T cell receptor alpha beta. Cell Immunol 144:382-391, 1992
19. + T cells. Immunol Invest 25:341-353, 1996
20. Yamaki K, Uchida H, Li X, Yanagisawa R, Takano H, Hayashi H, Mori Y, Yoshino S: Effect of varying types of antiarthritic drugs on Th1 and Th2 immune responses in mice. Int J Immunopathol Pharmacol 18:133-134, 2005
21. Brauer R, Kittlick PD, Thoss K, Henzgen S: Different immunological mechanisms contribute to cartilage destruction in antigen-induced arthritis. Exp Toxicol Pathol 46:383-388, 1994
22. Ding CH, Li Q, Xiong ZY, Zhou AW, Jones G, Xu SY: Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis. Clin Exp Immunol 132:416-423, 2003
23. Zou LP, Ma DH, Levi M, Wahren B, Wei L, Mix E, van der Meide PH, Link H, et al.: Antigen-specific immunosuppression: Nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 94:109-121, 1999
24. Derry CJ, Harper N, Davies DH, Murphy JJ, Staines NA: Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance. Arthritis Rheum 44:1917-1927, 2001
25. Hosoda T, Mito N, Yoshino H, Sato K: Estrogen altered oral tolerance induction in type II collagen-induced murine arthritis. Int Arch Allergy Immunol 133:19-28, 2004
26. Cobelens PM, Kavelaars A, Vroon A, Ringeling M, van der Zee R, van Eden W, Heijnen CJ: The β2-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity. J Immunol 169:5028-5035, 2002
27. Yoshino S, Quattrocchi E, Weiner HL: Suppression of antigen-induced arthritis in Lewis rats by oral administration of type II collagen. Arthritis Rheum 38:1092-1096, 1995
28. Xiao BG, Link H: Mucosal tolerance: A two-edged sword to prevent and treat autoimmune diseases. Clin Immunol Immunopathol 85:119-128, 1997
29. Vezys V, Lefrancois L: Cutting edge: Inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J Immunol 169:6677-6680, 2002
30. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742, 1997
31. + regulatory T cells by oral antigen administration. J Immunol 167:4245-4253, 2001
32. + T cells in the control of inflammation. J Immunol 171:5018-5026, 2003
33. Tsuji NM, Mizumachi K, Kurisaki J-I: Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 103:458-464, 2001
34. Unger WW, Hauet-Broere F, Jansen W, van Berkel LA, Kraal G, Samsom JN: Early events in peripheral regulatory T cell induction via the nasal mucosa. J Immunol 171:4592-4603, 2003
35. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
36. Inada S, Kohashi O, Hamasaki Y: Humoral immune-mediated acute, antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after, immunization. Immunol Invest 30:47-56, 2001
37. Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86:1976-1984, 1990
38. Orlova EV, Dube P, Harris JR, Beckman E, Zemlin F, Markl J, van Heel M: Structure of keyhole limpet hemocyanin type 1 (KLH1) at 15 Å resolution by electron cryomicroscopy and angular reconstitution. J Mol Biol 271:417-437, 1997
39. Barone KS, Reilly MR, Flanagan MP, Michael JG: Abrogation of oral tolerance by feeding encapsulated antigen. Cell Immunol 199:65-72, 2000
40. Maurano F, Siciliano RA, De Gioulio B, Luongo D, Mazzeo MF, Troncone R, Auricchio S, Rossi M: Intranasal administration of one alpha gliadin can downregulate the immune response to whole gliadin in mice. Scand J Immunol 53:290-295, 2001
41. Ben Nasser I, Boyaka PN, Ben Aissa FF, Jeddi M, Tome D: The [173-176] fragment of ovalbumin suppresses ovalbumin-specific rat IgE responses. Int Immunopharmacol 3:1569-1579, 2003
42. Gardine CA, Gentile F, Pellegrini C, Giallauria F, Torelli G, Kouki T, Kouki T, DeGroot L: Multiple fragments of human TG are capable of inducing oral tolerance to whole human TG. J Endocrinol Invest 26:294-300, 2003